Redefining ALS: Large-Scale Proteomic Profiling Reveals a Prolonged Pre-Diagnostic&amp;nbsp;Phase with Immune, Muscular, Metabolic, and Brain Involvement

Jan Homann; Roxanna Korologou‐Linden; Vivian Viallon; Sarah Morgan; Valerija Dobričić; Laura Deecke; Julia P. Schessner; Karl Smith-Byrne; Daniel Birtles; Yujia Zhao; Joanne Wuu; Fanny Artaud; Fatema Hajizadah; José María Huerta; Olena Ohlei; Mikhail Lebedev; P. Martijn Kolijn; Marcela Guevara; Ana Jiménez-Zabala; María‐José Sánchez; Camino Trobajo‐Sanmartín; Sandra M. Colorado‐Yohar; Sonia Alonso‐Martín; Dafina Petrova; Sabina Sieri; Klaus Berger; Susan Peters; Nicholas J. Wareham; R. Kaaks; Ruth C. Travis; Roel Vermeulen; Ioanna Tzoulaki; Alexis Elbaz; Matthias Mann; Carlotta Sacerdote; Giovanna Masala; Verena Katzke; Michael Benatar; Lars Bertram; Lefkos Middleton; Elio Riboli; Marc J. Gunter; Pietro Ferrari; Oliver Robinson; Christina M. Lill

doi:10.2139/ssrn.5398619

Related publications

Preprint2025

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement

Christina M. Lill, Jan Homann, Roxanna Korologou‐Linden, Vivian Viallon, Sarah Morgan, Valerija Dobričić, Laura Deecke, Julia P. Schessner, Karl Smith-Byrne, Daniel Birtles, Yujia Zhao, Joanne Wuu, Fanny Artaud, Fatema Hajizadah, José María Huerta, Olena Ohlei, Mikhail Lebedev, P. Martijn Kolijn, Marcela Guevara, Ana Jiménez-Zabala, María‐José Sánchez, Camino Trobajo‐Sanmartín, Sandra M. Colorado‐Yohar, Sonia Alonso‐Martín, Dafina Petrova, Sabina Sieri, Klaus Berger, Susan Peters, Nicholas J. Wareham, Rudolf Kaaks, Ruth C. Travis, Roel Vermeulen, Ioanna Tzoulaki, Alexis Elbaz, Matthias Mann, Carlotta Sacerdote, Giovanna Masala, Verena Katkze, Michael Benatar, Lars Bertram, Lefkos Middleton, Elio Riboli, Marc Gunter, Oliver Robinson, Pietro Ferrari

Preprint2025

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement

Jan Homann, Roxanna Korologou‐Linden, Vivian Viallon, Sarah Morgan, Valerija Dobričić, Laura Deecke, Julia P. Schessner, Karl Smith-Byrne, Daniel Birtles, Yujia Zhao, Joanne Wuu, Fanny Artaud, Fatema Hajizadah, José María Huerta, Olena Ohlei, Mikhail Lebedev, P. Martijn Kolijn, Marcela Guevara, Ana Jiménez-Zabala, María José Sánchez, Camino Trobajo‐Sanmartín, Sandra M. Colorado‐Yohar, Sonia Alonso‐Martín,

Article2007

Detailed Analysis of Variation at and around Mitochondrial Position 16189 in a Large Finnish Cohort Reveals No Significant Associations with Early Growth or Metabolic Phenotypes at Age 31 Years

Sreena Das, Amanda J. Bennett, Ulla Sovio, Aimo Ruokonen, Hannu Martikainen, Anneli Pouta, Anna‐Liisa Hartikainen, Stephen Franks, Paul Elliott, Joanna Poulton, Paul M Ridker, Mark I. McCarthy

Preprint2019

The Neuro-Immune Fingerprint of Major Neuro-Cognitive Psychosis or Deficit Schizophrenia:&nbsp;A&nbsp;Supervised Machine Learning Study

Hussein Kadhem Al‐Hakeim, Abbas F. Almulla, Michael Maes

Article2015

Tiotropium HandiHaler&reg; and Respimat&reg; in&nbsp;COPD:&nbsp;a pooled safety analysis

Christine Winchester, David Halpin, Ronald E Dahl, Christoph Hallmann, Achim Mueller, Donald P. Tashkin

Redefining ALS: Large-Scale Proteomic Profiling Reveals a Prolonged Pre-Diagnostic&nbsp;Phase with Immune, Muscular, Metabolic, and Brain Involvement

Discussion(0)

Open reviews(0)

Related publications

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement

Detailed Analysis of Variation at and around Mitochondrial Position 16189 in a Large Finnish Cohort Reveals No Significant Associations with Early Growth or Metabolic Phenotypes at Age 31 Years

The Neuro-Immune Fingerprint of Major Neuro-Cognitive Psychosis or Deficit Schizophrenia:&nbsp;A&nbsp;Supervised Machine Learning Study

Tiotropium HandiHaler&reg; and Respimat&reg; in&nbsp;COPD:&nbsp;a pooled safety analysis

Redefining ALS: Large-Scale Proteomic Profiling Reveals a Prolonged Pre-Diagnostic&amp;nbsp;Phase with Immune, Muscular, Metabolic, and Brain Involvement

Discussion(0)

Open reviews(0)

Related publications

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement

Detailed Analysis of Variation at and around Mitochondrial Position 16189 in a Large Finnish Cohort Reveals No Significant Associations with Early Growth or Metabolic Phenotypes at Age 31 Years

The Neuro-Immune Fingerprint of Major Neuro-Cognitive Psychosis or Deficit Schizophrenia:&amp;nbsp;A&amp;nbsp;Supervised Machine Learning Study

Tiotropium HandiHaler&amp;reg; and Respimat&amp;reg; in&amp;nbsp;COPD:&amp;nbsp;a pooled safety analysis

Redefining ALS: Large-Scale Proteomic Profiling Reveals a Prolonged Pre-Diagnostic Phase with Immune, Muscular, Metabolic, and Brain Involvement

The Neuro-Immune Fingerprint of Major Neuro-Cognitive Psychosis or Deficit Schizophrenia: A Supervised Machine Learning Study

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis